TD Asset Management’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $321K | Hold |
|
|||||
|
2025
Q1 | $432K | Hold |
|
|||||
|
2024
Q4 | $826K | Hold |
|
|||||
|
2024
Q3 | $786K | Sell |
|
|||||
|
2024
Q2 | $1.02M | Hold |
|
|||||
|
2024
Q1 | $1.01M | Sell |
|
|||||
|
2023
Q4 | $1.8M | Hold |
|
|||||
|
2023
Q3 | $1.88M | Buy |
|
|||||
|
2023
Q2 | $903K | Hold |
|
|||||
|
2023
Q1 | $865K | Hold |
|
|||||
|
2022
Q4 | $806K | Buy |
|
|||||
|
2022
Q3 | $925K | Buy |
|
|||||
|
2022
Q2 | $702K | Hold |
|
|||||
|
2022
Q1 | $542K | Hold |
|
|||||
|
2021
Q4 | $987K | Buy |
|